Anett
Anett Borgwardt, Au CH
Patent application number | Description | Published |
---|---|---|
20110076446 | PERFORATED LAMINATED POLYMERIC FOAM ARTICLES - A polymeric foam article has at least two thermoplastic polymer foams in layered orientation, each of the thermoplastic polymer foams having an adjoining surface that contains a polymer skin, a thickness dimension perpendicular to the adjoining surface, perforations that are less than one millimeter in diameter that penetrate through the adjoining surface to a depth less than the thickness dimension of the foam, where the adjoining surface of one thermoplastic polymer foam is adjacent and adhered to the adjoining surface of another thermoplastic polymer foam with an adhesive thereby affixing the thermoplastic polymer foams to one another. | 03-31-2011 |
Anett Borgwardt, Thalwil CH
Patent application number | Description | Published |
---|---|---|
20130034700 | LAMINATED FOAMS WITH MATING PEAKS AND GROOVES - A laminated foam article contains at least two foam boards having mating peak and groove surface profiles where surface skin remains on at least a portion of the profiles and wherein the foam boards are laminated to one another in a mating orientation with the peaks of one foam surface within the grooves of the adjoining foam surface with an adhesive between the mating surfaces of the foams and wherein the laminated foam article has a thickness that exceeds 200 millimeters. | 02-07-2013 |
Anett Gyurak, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20130102918 | SYSTEM AND METHOD FOR DIAGNOSING AND TREATING PSYCHIATRIC DISORDERS - Systems and methods for diagnosing and treating psychiatric disorders are provided. For example, in one embodiment, the systems and methods generally include: (a) presenting an emotional conflict task to a patient; (b) receiving an input from the patient in response to the emotional conflict task; (c) assessing the patient's response to the emotional conflict task; and (d) modifying the emotional conflict task based on the patient's response. Such systems and methods may also be employed in a computerized training system for treating a patient with, or at risk of, a psychiatric disorder by training the patient's implicit emotional regulation. | 04-25-2013 |
Anett Mueller, Chemnitz DE
Patent application number | Description | Published |
---|---|---|
20110311733 | Method For Curing And Surface-Functionalizing Molded Parts - The invention relates to the fields of chemistry and relates to a method for curing and surface modification of molded parts, which can be used, for example, in the automobile industry, in vehicle construction, in the electrical industry. The object of the present invention is to disclose a method which can be carried out in particular in a short time and with a high degree of reproducibility and leads to an improvement in the surface quality of the molded parts to be painted. The object is attained with a method in which materials containing at least one unsaturated radically or cationically curable reactive resin system are processed to form a molded part and during or after the molding process with or without coating are cross-linked up to dimensional stability, and during the cross-linking and/or subsequently, before and/or after a coating, the molded part is subjected to a processing by means of energetic radiation or energetic particles up to essentially complete curing at least of the surface region of the molded part. | 12-22-2011 |
Anett Perlberg, Gunzgen CH
Patent application number | Description | Published |
---|---|---|
20090088447 | SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHEN- YL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE - Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed. | 04-02-2009 |
20100016422 | SOLID FORMS OF (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(METHYLTHIO)TETR- AHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS OF THEIR USE - Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders. | 01-21-2010 |
20120157415 | New Crystalline Form of Pemirolast - There is provided a hemihydrate form of the sodium salt of pemirolast. | 06-21-2012 |
20130005754 | SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHEN- YL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE - Solid forms of (S)-ethyl 2-amino-3 -(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed. | 01-03-2013 |
20130165395 | METHODS OF TREATING DIABETES - Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders. | 06-27-2013 |
20130345239 | NOVEL CRYSTALLINE FORM - This invention relates to a new crystalline form of the succinate salt of the epithelial sodium channel (ENaC) blocker 3-(3-{2-[(E)-3,5-Diamino-6-chloro-pyrazine-2-carbonylimino]-1,3,8-triaza-spiro[4.5]decane-8-carbonyl}-benzenesulfonylamino)-propionic acid dipropylcarbamoylmethyl ester, pharmaceutical compositions comprising said crystalline form, uses of said crystalline form and pharmaceutical compositions, and methods for preparing said crystalline form. | 12-26-2013 |
20140329839 | New Crystalline Form of Pemirolast - There is provided a hemihydrate form of the sodium salt of pemirolast. | 11-06-2014 |
Anett Soeffing, Weimar DE
Patent application number | Description | Published |
---|---|---|
20120225913 | TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USE - The invention relates to inhibitors of trypsin-like serine proteases of the general formula (I) which, as well as plasmin, also inhibit plasma kallikrein, and to their preparation and use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive. | 09-06-2012 |
20130165510 | TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USE - The invention relates to inhibitors of trypsin-like serine proteases, including those of the general formula (IV) which, as well as plasmin, also inhibit plasma kallikrein, and to their use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive. | 06-27-2013 |
Anett Soffing, Weimar DE
Patent application number | Description | Published |
---|---|---|
20100022781 | TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, AND THEIR PREPARATION AND USE - The invention relates to inhibitors of trypsin-like serine proteases of the general formula (I) which, as well as plasmin, also inhibit plasma kallikrien, and to their preparation and use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive. | 01-28-2010 |